Market Cap 140.55B
Revenue (ttm) 23.88B
Net Income (ttm) 3.90B
EPS (ttm) N/A
PE Ratio 26.36
Forward PE 25.51
Profit Margin 16.33%
Debt to Equity Ratio 0.31
Volume 6,590,900
Avg Vol 4,040,572
Day's Range N/A - N/A
Shares Out 715.67M
Stochastic %K 24%
Beta 0.77
Analysts Strong Sell
Price Target $242.52

Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell cu...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 202 828 0850
Fax: 202 828 0860
Address:
2200 Pennsylvania Avenue N.W., Suite 800W, Washington, United States
Rage_Against_The_Machine
Rage_Against_The_Machine Jun. 19 at 3:33 PM
Danaher ($DHR) remains a key player in the $33B infectious disease testing market as demand shifts to next-gen POC solutions and molecular platforms. With 6.6% of revenue reinvested in R&D, their focus on sepsis/STI diagnostics could offset near-term margin pressures. Premium valuation demands flawless execution. https://www.prnewswire.com/news-releases/infectious-disease-testing-market-remains-dynamic-amid-post-pandemic-shifts-and-new-innovations-302485467.html
0 · Reply
StockAutoPro
StockAutoPro Jun. 16 at 10:13 PM
$DHR: At $201.11, stable. Buy around $200, target $205 with life sciences equipment demand steady.
0 · Reply
trading_momentum
trading_momentum Jun. 16 at 3:30 AM
$DHR, $A are its big competitors and continue to see earning growth contraction. EPA regulation rollback by current admin were destructive to top and bottom lines. Worried bout these names as LT share holder
0 · Reply
JarvisFlow
JarvisFlow Jun. 13 at 7:21 PM
RBC Capital has updated their rating for Danaher ( $DHR ) to Outperform with a price target of 250.
0 · Reply
JarvisFlow
JarvisFlow Jun. 13 at 7:10 PM
Baird has adjusted their stance on Danaher ( $DHR ), setting the rating to Outperform with a target price of 258 → 231.
0 · Reply
DonCorleone77
DonCorleone77 Jun. 2 at 11:31 AM
$DHR Danaher's SCIEX announces three software ecosystem enhancements SCIEX, an operating company of Danaher Corporation, announces three software ecosystem enhancements at ASMS. These developments will present new ways to acquire data, new standards for performance, and new practices to extract elevated insights, all supporting the theme that "all science is data science now." The new SCIEX OS software version 4.0 is the latest evolution of its software platform. AI Quantitation software ushers in a new era of artificial intelligence driven data processing automation. SCIEX supports the vibrant open-source software community with SCIEX MS Data Converter 2.0
0 · Reply
DonCorleone77
DonCorleone77 Jun. 2 at 11:18 AM
$DHR SCIEX, Evosep expand access to standardized proteomics SCIEX, an operating company of Danaher Corporation, and Evosep Biosystems enter a reseller agreement to co-sell SCIEX mass spectrometry systems with the newly announced Evosep Eno, for standardized high-throughput proteomics. The reseller agreement empowers researchers to implement standardized proteomics workflows, delivering a robust LC-MS solution designed to meet the evolving demands of pharmaceutical and biotech companies. With Evosep Eno, researchers gain exceptional throughput, sensitivity, and reproducibility.
0 · Reply
ZacksResearch
ZacksResearch May. 30 at 6:02 PM
$DHR partners with $AZN for precision medicine boost! 🚀 Danaher and AstraZeneca are teaming up to create AI-driven diagnostic tools, enhancing patient selection for precision treatments. This could improve global access to personalized medicine. Discover what this means for investors 👉 https://www.zacks.com/commentary/2479865/danaher-partners-with-astrazeneca-to-support-precision-medicine?cid=sm-stocktwits-2-2479865-body&ADID=SYND_STOCKTWITS_TWEET_2_2479865_BODY
0 · Reply
ZacksResearch
ZacksResearch May. 30 at 4:27 PM
$DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient selection and making advanced tests accessible worldwide. Know more: https://www.zacks.com/stock/news/2479865/danaher-partners-with-astrazeneca-to-support-precision-medicine?cid=sm-stocktwits-2-2479865-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2479865_TEASER
0 · Reply
jewell69
jewell69 May. 30 at 12:19 PM
$VEEV did everybody see hat $VEEV was up 28.5% yesterday 5/29 New topic $AI expert guest on cnbc yesterday with David Faber. Topic: $IBB $XBI stocks benefitting Many different ways ai can help them “Picks and shovels” that help XBI companies will benefit also $DHR
0 · Reply
Latest News on DHR
Danaher: High Capex And Low Debt Despite Trump Legislation

Jun 19, 2025, 12:33 PM EDT - 3 days ago

Danaher: High Capex And Low Debt Despite Trump Legislation


Danaher Announces Quarterly Dividend

May 6, 2025, 4:15 PM EDT - 6 weeks ago

Danaher Announces Quarterly Dividend


Danaher: Q1 Beat Fails To Trigger Guidance Upgrade

May 2, 2025, 4:00 AM EDT - 7 weeks ago

Danaher: Q1 Beat Fails To Trigger Guidance Upgrade


Danaher Corporation (DHR) Q1 2025 Earnings Call Transcript

Apr 22, 2025, 11:09 AM EDT - 2 months ago

Danaher Corporation (DHR) Q1 2025 Earnings Call Transcript


Danaher Reports First Quarter 2025 Results

Apr 22, 2025, 6:00 AM EDT - 2 months ago

Danaher Reports First Quarter 2025 Results


3 Wide-Moat Dividend Stars For A Championship Portfolio

Apr 2, 2025, 7:30 AM EDT - 2 months ago

3 Wide-Moat Dividend Stars For A Championship Portfolio

JNJ NEE


Danaher Corporation: A Mixed Bag Of Strength And Stagnation

Mar 31, 2025, 2:27 AM EDT - 2 months ago

Danaher Corporation: A Mixed Bag Of Strength And Stagnation


8 Upcoming Dividend Increases, Including A King

Mar 24, 2025, 5:06 PM EDT - 3 months ago

8 Upcoming Dividend Increases, Including A King

BBY CINF CSR DKS ELS KFY RNP


Danaher: Near 5-Year Low Is A Great Entry Point

Mar 22, 2025, 8:00 AM EDT - 3 months ago

Danaher: Near 5-Year Low Is A Great Entry Point


Danaher Schedules First Quarter 2025 Earnings Conference Call

Mar 20, 2025, 4:15 PM EDT - 3 months ago

Danaher Schedules First Quarter 2025 Earnings Conference Call


Danaher to Present at TD Cowen Health Care Conference

Feb 25, 2025, 4:15 PM EST - 4 months ago

Danaher to Present at TD Cowen Health Care Conference


Danaher Increases Quarterly Dividend

Feb 20, 2025, 4:15 PM EST - 4 months ago

Danaher Increases Quarterly Dividend


Danaher: Self-Inflicted Pessimism?

Feb 17, 2025, 1:46 AM EST - 4 months ago

Danaher: Self-Inflicted Pessimism?


3 Top Value Stocks to Buy and Hold for 2025

Feb 11, 2025, 11:05 AM EST - 4 months ago

3 Top Value Stocks to Buy and Hold for 2025

CPB UPS


Danaher Analysts Cut Their Forecasts After Downbeat Earnings

Jan 30, 2025, 9:02 AM EST - 5 months ago

Danaher Analysts Cut Their Forecasts After Downbeat Earnings


Danaher Corporation (DHR) Q4 2024 Earnings Call Transcript

Jan 29, 2025, 11:20 AM EST - 5 months ago

Danaher Corporation (DHR) Q4 2024 Earnings Call Transcript


Danaher misses quarterly profit estimates on weak biotech demand

Jan 29, 2025, 7:02 AM EST - 5 months ago

Danaher misses quarterly profit estimates on weak biotech demand


Danaher Reports Fourth Quarter and Full Year 2024 Results

Jan 29, 2025, 6:00 AM EST - 5 months ago

Danaher Reports Fourth Quarter and Full Year 2024 Results


3 Top Blue-Chip Stocks to Buy and Hold for 2025

Jan 21, 2025, 11:00 AM EST - 5 months ago

3 Top Blue-Chip Stocks to Buy and Hold for 2025

MSFT PEP


Danaher: Transition Year Recap

Jan 16, 2025, 7:46 AM EST - 5 months ago

Danaher: Transition Year Recap


Danaher CEO to Comment on Financial Performance

Jan 13, 2025, 4:15 PM EST - 5 months ago

Danaher CEO to Comment on Financial Performance


Danaher Announces Investment Partnership in Innovaccer Inc.

Jan 9, 2025, 4:15 PM EST - 5 months ago

Danaher Announces Investment Partnership in Innovaccer Inc.


Danaher to Present at J.P. Morgan Healthcare Conference

Jan 6, 2025, 4:15 PM EST - 5 months ago

Danaher to Present at J.P. Morgan Healthcare Conference


Danaher: A Wide-Moat Gem I Cannot Buy Enough Of

Jan 6, 2025, 9:00 AM EST - 5 months ago

Danaher: A Wide-Moat Gem I Cannot Buy Enough Of


Rage_Against_The_Machine
Rage_Against_The_Machine Jun. 19 at 3:33 PM
Danaher ($DHR) remains a key player in the $33B infectious disease testing market as demand shifts to next-gen POC solutions and molecular platforms. With 6.6% of revenue reinvested in R&D, their focus on sepsis/STI diagnostics could offset near-term margin pressures. Premium valuation demands flawless execution. https://www.prnewswire.com/news-releases/infectious-disease-testing-market-remains-dynamic-amid-post-pandemic-shifts-and-new-innovations-302485467.html
0 · Reply
StockAutoPro
StockAutoPro Jun. 16 at 10:13 PM
$DHR: At $201.11, stable. Buy around $200, target $205 with life sciences equipment demand steady.
0 · Reply
trading_momentum
trading_momentum Jun. 16 at 3:30 AM
$DHR, $A are its big competitors and continue to see earning growth contraction. EPA regulation rollback by current admin were destructive to top and bottom lines. Worried bout these names as LT share holder
0 · Reply
JarvisFlow
JarvisFlow Jun. 13 at 7:21 PM
RBC Capital has updated their rating for Danaher ( $DHR ) to Outperform with a price target of 250.
0 · Reply
JarvisFlow
JarvisFlow Jun. 13 at 7:10 PM
Baird has adjusted their stance on Danaher ( $DHR ), setting the rating to Outperform with a target price of 258 → 231.
0 · Reply
DonCorleone77
DonCorleone77 Jun. 2 at 11:31 AM
$DHR Danaher's SCIEX announces three software ecosystem enhancements SCIEX, an operating company of Danaher Corporation, announces three software ecosystem enhancements at ASMS. These developments will present new ways to acquire data, new standards for performance, and new practices to extract elevated insights, all supporting the theme that "all science is data science now." The new SCIEX OS software version 4.0 is the latest evolution of its software platform. AI Quantitation software ushers in a new era of artificial intelligence driven data processing automation. SCIEX supports the vibrant open-source software community with SCIEX MS Data Converter 2.0
0 · Reply
DonCorleone77
DonCorleone77 Jun. 2 at 11:18 AM
$DHR SCIEX, Evosep expand access to standardized proteomics SCIEX, an operating company of Danaher Corporation, and Evosep Biosystems enter a reseller agreement to co-sell SCIEX mass spectrometry systems with the newly announced Evosep Eno, for standardized high-throughput proteomics. The reseller agreement empowers researchers to implement standardized proteomics workflows, delivering a robust LC-MS solution designed to meet the evolving demands of pharmaceutical and biotech companies. With Evosep Eno, researchers gain exceptional throughput, sensitivity, and reproducibility.
0 · Reply
ZacksResearch
ZacksResearch May. 30 at 6:02 PM
$DHR partners with $AZN for precision medicine boost! 🚀 Danaher and AstraZeneca are teaming up to create AI-driven diagnostic tools, enhancing patient selection for precision treatments. This could improve global access to personalized medicine. Discover what this means for investors 👉 https://www.zacks.com/commentary/2479865/danaher-partners-with-astrazeneca-to-support-precision-medicine?cid=sm-stocktwits-2-2479865-body&ADID=SYND_STOCKTWITS_TWEET_2_2479865_BODY
0 · Reply
ZacksResearch
ZacksResearch May. 30 at 4:27 PM
$DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient selection and making advanced tests accessible worldwide. Know more: https://www.zacks.com/stock/news/2479865/danaher-partners-with-astrazeneca-to-support-precision-medicine?cid=sm-stocktwits-2-2479865-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2479865_TEASER
0 · Reply
jewell69
jewell69 May. 30 at 12:19 PM
$VEEV did everybody see hat $VEEV was up 28.5% yesterday 5/29 New topic $AI expert guest on cnbc yesterday with David Faber. Topic: $IBB $XBI stocks benefitting Many different ways ai can help them “Picks and shovels” that help XBI companies will benefit also $DHR
0 · Reply
RunnerSignals
RunnerSignals May. 22 at 3:45 AM
Options buzz on $ANET $APP $CRDO showing promise with strong calls while $BX $CVX $DHR lean bearish. $FTNT might rebound stocksrunner.com/news/2025-05-21-options-market-buzz-signal-potential-breakouts
0 · Reply
Stretch_Armstrong
Stretch_Armstrong May. 21 at 4:09 PM
$DHR waiting to grab more on the double bottom
1 · Reply
OnlyFibs
OnlyFibs May. 21 at 12:10 AM
$DHR - this got slammed, and has been quietly gaining traction and buy volume, we closed over the 50sma by a few pennies, last time was 4 months ago, its brewing, gl! #hovdid
0 · Reply
ahab
ahab May. 18 at 2:58 PM
$SPY upper tier 1.8% - 3.6% middle of the herd 2.7% boring stocks $CNC, $WST, $DHR, $NRG
1 · Reply
Stretch_Armstrong
Stretch_Armstrong May. 18 at 3:12 AM
0 · Reply
Determinedstocks
Determinedstocks May. 16 at 12:07 AM
$BEAM $PRME $DHR Could this story lift the rest of this sector? https://www.nytimes.com/2025/05/15/health/gene-editing-personalized-rare-disorders.html?smid=url-share
0 · Reply
Popo_Jijo
Popo_Jijo May. 15 at 1:51 PM
$DHR down to about 20x on the forward look this morning. Re-rating complete-ish. Getting back in.
0 · Reply
mpgolfpro
mpgolfpro May. 14 at 3:01 PM
$DHR This thing feels super manipulated lately. Up to 200 back down to 190, rinse and repeat the last couple months. Someone out there does not want this to break out past 200.
0 · Reply
codename41
codename41 May. 12 at 9:15 PM
$DHR loaded
0 · Reply
Nikotes
Nikotes May. 12 at 6:25 PM
0 · Reply
Quantumup
Quantumup May. 12 at 3:53 PM
BofA Asks and Answers: on a, "Potential reset / reduction of China tariffs: Who stands to benefit the most? — Biggest beneficiaries: $TMO [Buy-$545], $AVTR , $DHR [Buy-$230], $RVTY [Buy-$116], MTD, ILMN [Underperform-$70]" ELAN BofA said in its note:
0 · Reply
Nikotes
Nikotes May. 12 at 2:59 PM
New free to read article released: The Serial Acquirers Playbook. Underappreciated quality traits of these businesses with real-world examples, like $CSU.TSX $HEI or $DHR Link's in profile and below at Expanse Stocks: https://expansestocks.substack.com/p/the-serial-acquirers-playbook-a-primer
0 · Reply